Graviton Bioscience


Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.

Employees

11-50

Links


Org chart

Samuel Waksal
Chief Executive Officer
Collapse
Julia Balanova
Vp, Corporate Strategy And Communications
Christie Matsui
Chief People Officer
Amy Melsaether
Chief Medical Officer
Suacer M. Tejeda
Director IT And Cybersecurity